Loading
Latest filing published 11 Mar 2026 for Aquestive Therapeutics, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Lori J. Braender is a declared insider of Aquestive Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). In total, 6 filings cover trades dated from 8 June 2022 to 9 March 2026.
Every open-market trade on record is a purchase: 1 purchase worth €12k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants.
The latest filing, published on 11 March 2026, reports a share grant in Aquestive Therapeutics, Inc. The clock since the last published purchase (10 June 2022) now reads 1,591 days. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations